Carcinoma de pulmón no microcíticoFase 2NCT06918132
Resectable lung cancer: cemiplimab and fianlimab before surgery
Biospecimen Collection, Cemiplimab, Fianlimab, Magnetic Resonance Imaging
98 estudios reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Pulmón y tórax98 estudios
Carcinoma de pulmón no microcíticoFase 2NCT06918132
Biospecimen Collection, Cemiplimab, Fianlimab, Magnetic Resonance Imaging
Non Small Cell Lung Cancer MetastaticFase 2NCT06741085
osimertinib, stereotactic radiosurgery (SRS)
Carcinoma de pulmón no microcíticoFase 2NCT06014827
Biospecimen Collection, Computed Tomography, Osimertinib, Positron Emission Tomography
Advanced Lung Non-Small Cell CarcinomaFase 2NCT03191149
Biospecimen Collection, Computed Tomography with Contrast, Echocardiography Test, Magnetic Resonance Imaging
Carcinoma, Non-Small-Cell LungFase 2NCT06780085
Raludotatug Deruxtecan, Ifinatamab Deruxtecan, Docetetaxel, 5-hydroxytryptamine subtype 3 receptor antagonist
Small Cell Lung CancerFase 2NCT07155174
ABBV-706, Atezolizumab, Etoposide, Carboplatin
Cáncer de pulmón no microcíticoFase 2NCT05168566Artículos
Sutetinib Maleate Capsule
Peritoneal Malignant MesotheliomaFase 2NCT05001880Artículos
Atezolizumab, Bevacizumab, Biospecimen Collection, Carboplatin
Small Cell Lung CancerFase 2NCT07551635
FHD-286
Metastatic Non-Squamous Non-Small Cell Lung CancerFase 2NCT07246863
Visugromab RDE (recommended dose for expansion), Visugromab 6mg/kg, Nivolumab, Placebo Saline Infusion
Cáncer de pulmón no microcíticoFase 2NCT06568939
Telisotuzumab Vedotin
Cáncer de pulmón no microcíticoFase 2NCT07154290
Ubamatamab, Marlotamig, Sarilumab
Lung CancerFase 2NCT03290534
CivaSheet
Cáncer de pulmón no microcíticoFase 2NCT05061550Artículos
Durvalumab, Oleclumab, Monalizumab, Dato-DXd
Advanced Non-Small Cell Lung CancerFase 2NCT02133196Artículos
Aldesleukin, Fludarabine, Cyclophosphamide, Young TIL
Carcinoma de pulmón no microcíticoFase 2NCT07293247
Chemotherapy, Immunotherapy, Intensity-Modulated Radiation Therapy, Computed Tomography
Cáncer de pulmón no microcíticoFase 2NCT06305715
Radiation Therapy, Targeted TKI therapy
Metastatic Non-Squamous Non-Small Cell Lung CancerFase 2NCT07098988
Visugromab, Matching placebo for visugromab, Pembrolizumab 200 mg Q3W, Pemetrexed 500 mg/m^2
Cáncer de pulmón no microcíticoFase 2NCT06731907
Pembrolizumab, Carboplatin, Paclitaxel, Nab-paclitaxel
Endocrine TumorsFase 2NCT03412877Artículos
Cyclophosphamide, Fludarabine, Aldesleukin, Individual Patient TCR-Transduced PBL
MesoteliomaFase 2NCT05960773
Decitabine/cedazuridine
Carcinoma de pulmón no microcíticoFase 2NCT07288034
Adagrasib, Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Bevacizumab
Thymic Epithelial TumorFase 2NCT05104736
PT-112
MesoteliomaFase 1NCT06885697
Células CAR T TNaive/SCM hYP218 (TNhYP218) anti-mesotelina en participantes con tumores sólidos que expresan mesotelina, incluido el mesotelioma